Beta-blockers after acute myocardial infarction
24 results
1 - 24
Beta-blockers after acute myocardial infarction 
Continued beta-blocker use after acute myocardial infarction (AMI) reduces hospitalizations but not cardiovascular death, AMI, or stroke- Beta-blockers in patients without heart failure after myocardial infarction
Beta‐blockers in patients without heart failure after myocardial infarction- Acute coronary syndrome
- Beta‐blockers for suspected or diagnosed acute myocardial infarction
- Chronic coronary syndrome (coronary heart disease)
- Sick sinus syndrome
- Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an acute cardiovascular event
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity
- In ACS, 5 yrs of invasive tx decreases MI but not all cause mortality (FRISC-II)
- The use of diltiazem, verapamil and short-acting nifedipine in heart failure
- Prehospital emergency care
- Syncope: causes and investigations
- Management of acute atrial fibrillation
- Chronic heart failure
- Aldosterone receptor antagonists spironolactone and eplerenone for congestive heart failure